To address the unmet medical needs of our patients with paradigm-shifting therapeutics.
We derive our name from the latin word vincēre meaning
VIP152 inhibits PTEFb phosphorylation of RNA polymerase II (RNAPII), thereby preventing transcription elongation and blocking expression of genes that drive cancer.
Vincerx Pharma Announces Completion of Public Warrant Redemption
PALO ALTO, Calif. , May 06, 2021 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (Nasdaq: VINC) (the “Company”), today announced the completion of its redemption event with respect to its outstanding public warrants (the “Public Warrants”). The Company issued a press release on April 5, 2021 , stating